Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-06

FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for desoximetasone by Sun Pharmaceutical Industries, enabling changes to the product's labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desoximetasone (Desoximetasone)

Snippet

SUPPL AP for DESOXIMETASONE (DESOXIMETASONE)